General Information of Drug (ID: DMX09KI)

Drug Name
CRT0066101 Drug Info
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Investigative [1]
Cross-matching ID
PubChem CID
136664697
TTD Drug ID
DMX09KI

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug(s) Targeting Protein kinase D (PRKD1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
G6976 DMEZO4M Solid tumour/cancer 2A00-2F9Z Investigative [2]
K252a DMT68RG Solid tumour/cancer 2A00-2F9Z Investigative [2]
BPKDi DM5OHIY Solid tumour/cancer 2A00-2F9Z Investigative [2]
CID755673 DMSHIQA Solid tumour/cancer 2A00-2F9Z Investigative [2]
INDUS-815B DMBOQ6M Kidney disease GC2Z Investigative [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Protein kinase D (PRKD1) TTSLUMT KPCD1_HUMAN Inhibitor [2]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8048).
2 Protein kinase D as a potential new target for cancer therapy. Biochim Biophys Acta. 2010 Dec;1806(2):183-92.
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1489).